RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Transmedics Group Stocks 2024

Transmedics Group Stocks

32.52 M

Transmedics Group Dividend yield

Ticker

TMDX

ISIN

US89377M1099

WKN

A2PH5P

In 2024, Transmedics Group had 32.52 M outstanding stocks, a 0% change from the 32.52 M stocks in the previous year.

The Transmedics Group Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2027e32.52
2026e32.52
2025e32.52
2024e32.52
202332.52
202229.56
202127.62
202024.7
201914.2
201820.24
201720.24
201620.24

Transmedics Group Aktienanalyse

What does Transmedics Group do?

Transmedics Group Inc is a company dedicated to the development and manufacturing of medical devices for organ transplantation. The company was founded in 1998 and is headquartered in Andover, Massachusetts, USA. Transmedics' business model is based on offering a unique and innovative technology for organ preservation during transport from donor to recipient. The patented Organ Care System (OCS) platform includes a range of state-of-the-art medical devices specifically designed for organ transport. Transmedics' Organ Care System includes three main devices: OCS Heart, OCS Lung, and OCS Liver. Each device is tailored for organ preparation and transport, providing individualized support based on the specific requirements of each organ and different transfer protocols. The OCS technology uses hypothermic (cold) perfusion to preserve the organ during transport. By continuously monitoring and supporting the organ's physiological functions, the OCS system can improve the survival rate of donor organs while reducing the time spent outside the body. Transmedics also offers comprehensive services, including the availability of OCS devices and qualified personnel to provide support throughout the transplantation process. Transmedics' customers include leading transplant centers and hospitals worldwide. The company works closely with these customers to ensure that its OCS devices meet the specific requirements of each transplantation program and help them achieve more successful transplantations. Transmedics' history is marked by a passion for improving transplantation medicine and saving lives through the provision of advanced technologies and solutions. The company has made significant progress in recent years and has experienced strong growth in all areas. Transmedics has also received a number of awards and recognition for its commitment to improving transplantation medicine. For example, in 2020, the company received the Red Herring Top 100 Global Award and was recognized for the seventh consecutive year as one of the fastest-growing companies by Deloitte. Overall, Transmedics is a leading provider of innovative medical devices for transplantation medicine. Through its organic technology and comprehensive service, the company supports transplant centers and hospitals worldwide in performing more successful transplantations and saving patients' lives. Transmedics Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Transmedics Group's Shares Outstanding

Transmedics Group's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Transmedics Group’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Transmedics Group’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Transmedics Group’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Transmedics Group Stock

How many stocks are there of Transmedics Group?

The current number of stocks of Transmedics Group is 32.52 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Transmedics Group are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Transmedics Group evolved in recent years?

The number of shares of Transmedics Group has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Transmedics Group as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Transmedics Group?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Transmedics Group pay?

Over the past 12 months, Transmedics Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Transmedics Group is expected to pay a dividend of 0 USD.

What is the dividend yield of Transmedics Group?

The current dividend yield of Transmedics Group is .

When does Transmedics Group pay dividends?

Transmedics Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Transmedics Group?

Transmedics Group paid dividends every year for the past 0 years.

What is the dividend of Transmedics Group?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Transmedics Group located?

Transmedics Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Transmedics Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Transmedics Group from 6/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/1/2024.

When did Transmedics Group pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of Transmedics Group in the year 2023?

In the year 2023, Transmedics Group distributed 0 USD as dividends.

In which currency does Transmedics Group pay out the dividend?

The dividends of Transmedics Group are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Transmedics Group

Our stock analysis for Transmedics Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Transmedics Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.